CR9037A - Celulas estromales hepaticas para el tratamiento y la prevencion de las respuestas inmunologicas en transplantes - Google Patents

Celulas estromales hepaticas para el tratamiento y la prevencion de las respuestas inmunologicas en transplantes

Info

Publication number
CR9037A
CR9037A CR9037A CR9037A CR9037A CR 9037 A CR9037 A CR 9037A CR 9037 A CR9037 A CR 9037A CR 9037 A CR9037 A CR 9037A CR 9037 A CR9037 A CR 9037A
Authority
CR
Costa Rica
Prior art keywords
stromal cells
treatment
transplants
prevention
immunological responses
Prior art date
Application number
CR9037A
Other languages
English (en)
Inventor
R Mcintosh Kevin
Original Assignee
Cognate Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognate Therapeutics Inc filed Critical Cognate Therapeutics Inc
Publication of CR9037A publication Critical patent/CR9037A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion incluye metodos y composiciones para reducir una respuesta a inmune a un transplante en un receptor al tratar al receptor con una cantidad de celulas estromales de higado efectiva para reducir o inhibir el rechazo de hospedero del transplante; asimismo, se describe un metodo para inducir una respuesta inmune reducida contra un hospedero por tejido extrano, es decir, enfermedad de injerto contra hospedero, mediante tratamiento con celulas estromales de higado.
CR9037A 2004-09-10 2007-04-09 Celulas estromales hepaticas para el tratamiento y la prevencion de las respuestas inmunologicas en transplantes CR9037A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60907704P 2004-09-10 2004-09-10

Publications (1)

Publication Number Publication Date
CR9037A true CR9037A (es) 2007-10-07

Family

ID=36060533

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9037A CR9037A (es) 2004-09-10 2007-04-09 Celulas estromales hepaticas para el tratamiento y la prevencion de las respuestas inmunologicas en transplantes

Country Status (16)

Country Link
US (2) US9408876B2 (es)
EP (1) EP1799236B1 (es)
JP (1) JP5089389B2 (es)
KR (1) KR20070073773A (es)
CN (1) CN101083910B (es)
AU (1) AU2005285222B2 (es)
CA (1) CA2579835A1 (es)
CR (1) CR9037A (es)
DK (1) DK1799236T3 (es)
ES (1) ES2390503T3 (es)
IL (1) IL181793A0 (es)
MX (1) MX2007004235A (es)
RU (1) RU2007113444A (es)
SG (1) SG158124A1 (es)
TW (1) TWI374188B (es)
WO (1) WO2006031539A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012156968A2 (en) 2011-05-19 2012-11-22 Ariel - University Research And Development Company, Ltd. Use of mesenchymal stem cells for the improvement of affective and cognitive function
WO2016026854A2 (en) * 2014-08-18 2016-02-25 Apceth Gmbh & Co. Kg Genetically modified mesenchymal stem cells expressing an immune response-stimulating cytokine to attract and/or activate immune cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733542A (en) * 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
DE69331778T2 (de) * 1992-01-08 2002-11-14 The General Hospital Corp., Boston Induzierte toleranz gegen transplantate
US6368636B1 (en) * 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US6328960B1 (en) * 1998-03-18 2001-12-11 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US6685936B2 (en) * 1999-10-12 2004-02-03 Osiris Therapeutics, Inc. Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation

Also Published As

Publication number Publication date
IL181793A0 (en) 2007-07-04
CN101083910A (zh) 2007-12-05
EP1799236B1 (en) 2012-05-23
CN101083910B (zh) 2012-06-27
EP1799236A2 (en) 2007-06-27
US9408876B2 (en) 2016-08-09
TWI374188B (en) 2012-10-11
HK1108599A1 (en) 2008-05-16
WO2006031539A3 (en) 2006-12-14
AU2005285222B2 (en) 2013-01-17
CA2579835A1 (en) 2006-03-23
WO2006031539A2 (en) 2006-03-23
TW200621986A (en) 2006-07-01
ES2390503T3 (es) 2012-11-13
SG158124A1 (en) 2010-01-29
DK1799236T3 (da) 2012-09-03
EP1799236A4 (en) 2009-07-15
US20060057125A1 (en) 2006-03-16
KR20070073773A (ko) 2007-07-10
MX2007004235A (es) 2007-10-03
JP2008512464A (ja) 2008-04-24
RU2007113444A (ru) 2008-10-27
JP5089389B2 (ja) 2012-12-05
AU2005285222A1 (en) 2006-03-23
US20160324900A1 (en) 2016-11-10

Similar Documents

Publication Publication Date Title
Bu et al. Dried plum polyphenols inhibit osteoclastogenesis by downregulating NFATc1 and inflammatory mediators
CR9676A (es) Inmunofenotipo e inmunogenicidad de celulas derivadas de tejido adiposo humano
ECSP15022090A (es) Composición que comprende agentes de control biológico
EP1220611A4 (en) SUPPRESSOR CELLS FOR THE PREVENTION AND TREATMENT OF IMMUNE RESPONSES IN TRANSPLANTATIONS
ECSP15022075A (es) Composición que comprende un agente de control biológico y un fungicida
EA201101189A1 (ru) Ингибитор sglt-2, предназначенный для лечения сахарного диабета типа 1, сахарного диабета типа 2, нарушенной толерантности к глюкозе или гипергликемии
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
PT1066052E (pt) Celulas estaminais mesenquimatosas para a prevencao e tratamento
MX2010003291A (es) Supresion de tumores utilizando perfundido placentario humano y células destructoras naturales intermediarias derivadas de la placenta humana.
EA200870019A1 (ru) Лактамовые соединения и способы их применения
MA33654B1 (fr) Compositions et procédés pour la lutte contre les nématodes et les maladies apportées par le sol
EA200800726A1 (ru) Введение ингибиторов дипептидилпептидазы
WO2008154149A3 (en) Tissue processing for nonimmunogenic implants
MX2008016453A (es) Composiciones y metodos para tratar infecciones parasitas.
CL2020002011A1 (es) Método para producir células asesinas naturales (nk) y composición para el tratamiento de cáncer
MX2015011544A (es) Metodos y detergentes enzimaticos para la eliminacion de biopelicula.
CL2011000877A1 (es) Composicion inmunogena para el tratamiento y/o profilaxis de ganado contra infecciones microbiologicas porque comprende antigeno de mycoplasma bovis; metodo de coadministracion de dos o mas antigenos a un ganado bovino.
EA200701600A1 (ru) Способ получения лёгкодоступного клеточного материала из периферической крови и композиция на его основе
EA200701995A1 (ru) Способы уменьшения кальцификации
ECSP088578A (es) Enzimas para estrés inmunológico reducido
CR9037A (es) Celulas estromales hepaticas para el tratamiento y la prevencion de las respuestas inmunologicas en transplantes
MX2016015635A (es) Metodos y composiciones para evitar la lesion por isquemia-reperfusion en organos.
EA200800206A1 (ru) Комбинированное применение метконазола и эпоксиконазола для уменьшения или предотвращения заражения зерновых культур микотоксинами
CU20110128A7 (es) Composiciones, métodos y usos para inducir el crecimiento viral
EP4491716A3 (en) Methods of isolating and using descemet's membrane and compositions including isolated descemet's membrane

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)